- Home
- EMA vs SNN Comparison
EMA vs SNN Comparison
Compare EMA & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EMA | SNN |
|---|---|---|
| Founded | 1998 | 1856 |
| Country | Canada | United Kingdom |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Industrial Specialties |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.3B | 14.0B |
| IPO Year | N/A | 1999 |
Fundamental Metrics
Financial Performance| Metric | EMA | SNN |
|---|---|---|
| Price | $49.19 | $32.82 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $32.83 |
| AVG Volume (30 Days) | 227.4K | ★ 492.7K |
| Earning Date | 02-07-2026 | 03-02-2026 |
| Dividend Yield | ★ 4.23% | 2.23% |
| EPS Growth | ★ 67.89 | 59.91 |
| EPS | ★ 2.65 | 0.56 |
| Revenue | ★ $6,126,111,896.00 | $5,944,000,000.00 |
| Revenue This Year | $22.93 | $7.71 |
| Revenue Next Year | N/A | $5.23 |
| P/E Ratio | ★ $18.73 | $28.52 |
| Revenue Growth | ★ 15.17 | 5.35 |
| 52 Week Low | $35.64 | $23.69 |
| 52 Week High | $49.77 | $38.79 |
Technical Indicators
Market Signals| Indicator | EMA | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 62.10 | 46.47 |
| Support Level | $47.70 | $32.66 |
| Resistance Level | $48.98 | $33.23 |
| Average True Range (ATR) | 0.58 | 0.41 |
| MACD | 0.15 | 0.10 |
| Stochastic Oscillator | 92.08 | 42.16 |
Price Performance
Historical ComparisonAbout EMA Emera Incorporated
Emera is a geographically diverse energy and services company investing in electricity generation, transmission, and distribution as well as gas transmission and utility energy services. Emera has operations throughout North America and the Caribbean countries.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.